Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Lupin Ltd

NSE: LUPIN · BSE: 500257 · Pharmaceuticals & Biotechnology · 57 announcements

Lupin Ltd news stories on ALFA NewsRead the news →
Share price
₹2,006.90
Market cap
₹91,774 Cr
Revenue (annual)
₹27,958 Cr
Net profit (annual)
₹5,333 Cr
P/E (TTM)
16.6×Sector 47.4×
Promoter holding
46.85%-0.01% QoQ
FII holding
22.42%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

06:51 IST BSE
Legal & Regulatory

Lupin Legal & Regulatory

Lupin's US subsidiary, LPI, entered a USD 30 million (₹279 Crore) settlement agreement with Humana Inc. to resolve antitrust litigation in Philadelphia. Lupin denies all allegations of anticompetitive behavior. The settlement amount was already accounted for in prior financial results, ensuring no fresh impact on consolidated earnings.

Value
₹279.0 Cr